+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Gene Therapy Market Research Report by Type (Antigen Gene Therapy, Cancer Gene Therapy, and Cytokine Gene Therapy), Vector Type, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4858031
  • Report
  • April 2022
  • Region: Global
  • 181 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Adaptimmune
  • Akcea Therapeutics
  • AnGes, Inc.
  • Biogen
  • Dynavax Technologies
  • Gilead Sciences, Inc.
The Global Gene Therapy Market size was estimated at USD 2,828.62 million in 2021, USD 3,463.59 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 22.62% to reach USD 9,617.32 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Gene Therapy to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy, Suicide Gene Therapy, and Tumor Suppressor Gene Therapy.
  • Based on Vector Type, the market was studied across Non-viral Vectors and Viral Vectors.
  • Based on Application, the market was studied across Cardiovascular Diseases, Genetic Diseases, Infectious Diseases, Neurological Diseases, and Oncological Disorders.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Gene Therapy market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Gene Therapy Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Gene Therapy Market, including Abeona Therapeutics, Inc.,, Achieve Life Sciences, Inc., Adaptimmune, AGTC, Akcea Therapeutics, Alnylam Pharmaceuticals, Inc., Amgen, Inc., AnGes, Inc., Audentes Therapeutics, Biogen, Bluebird bio, Inc., Dynavax Technologies, Editas Medicine, Gilead Sciences, Inc., Human Stem Cells Institute, Jazz Pharmaceuticals, Inc., Merck & Co., Inc, MolMed S.p.A., Novartis AG, Orchard Therapeutics plc., Sarepta Therapeutics, Inc., Sibiono GeneTech Co. Ltd., and Spark Therapeutics, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Gene Therapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Gene Therapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Gene Therapy Market?
4. What is the competitive strategic window for opportunities in the Global Gene Therapy Market?
5. What are the technology trends and regulatory frameworks in the Global Gene Therapy Market?
6. What is the market share of the leading vendors in the Global Gene Therapy Market?
7. What modes and strategic moves are considered suitable for entering the Global Gene Therapy Market?
Frequently Asked Questions about the Global Gene Therapy Market

What is the estimated value of the Global Gene Therapy Market?

The Global Gene Therapy Market was estimated to be valued at $2828.6 Million in 2021.

What is the growth rate of the Global Gene Therapy Market?

The growth rate of the Global Gene Therapy Market is 22.6%, with an estimated value of $9617.3 Million by 2027.

What is the forecasted size of the Global Gene Therapy Market?

The Global Gene Therapy Market is estimated to be worth $9617.3 Million by 2027.

Who are the key companies in the Global Gene Therapy Market?

Key companies in the Global Gene Therapy Market include Abeona Therapeutics, Inc.,, Achieve Life Sciences, Inc., Adaptimmune, AGTC, Akcea Therapeutics, Alnylam Pharmaceuticals, Inc., Amgen, Inc., AnGes, Inc. and Biogen.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Adaptimmune
  • Akcea Therapeutics
  • AnGes, Inc.
  • Biogen
  • Dynavax Technologies
  • Gilead Sciences, Inc.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant way of treatment to eradicates the practice of surgery, drugs, or other procedures that lead to side effects on the health of individuals
5.1.1.2. Innovation in gene therapy for rare & cardiovascular diseases treatment coupled with the awareness regarding the ability of gene therapy
5.1.1.3. Application in the treatment of various diseases such as cancer, haemophilia, parkinson’s disease, and HIV
5.1.1.4. Government support and ethical acceptance of gene therapy for cancer treatment
5.1.2. Restraints
5.1.2.1. High cost associated with the gene therapies
5.1.3. Opportunities
5.1.3.1. Upsurge in a number of gene therapy treatment centers in developed countries
5.1.3.2. Increasing adoption for gene therapy for the oncological disorder
5.1.3.3. Growing strategic alliances and ongoing research for orphan diseases
5.1.4. Challenges
5.1.4.1. Potential disorders associated with the immune response
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Gene Therapy Market, by Type
6.1. Introduction
6.2. Antigen Gene Therapy
6.3. Cancer Gene Therapy
6.4. Cytokine Gene Therapy
6.5. Suicide Gene Therapy
6.6. Tumor Suppressor Gene Therapy
7. Gene Therapy Market, by Vector Type
7.1. Introduction
7.2. Non-viral Vectors
7.3. Viral Vectors
8. Gene Therapy Market, by Application
8.1. Introduction
8.2. Cardiovascular Diseases
8.3. Genetic Diseases
8.4. Infectious Diseases
8.5. Neurological Diseases
8.6. Oncological Disorders
9. Americas Gene Therapy Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Gene Therapy Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Gene Therapy Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abeona Therapeutics, Inc.,
13.2. Achieve Life Sciences, Inc.
13.3. Adaptimmune
13.4. AGTC
13.5. Akcea Therapeutics
13.6. Alnylam Pharmaceuticals, Inc.
13.7. Amgen, Inc.
13.8. AnGes, Inc.
13.9. Audentes Therapeutics
13.10. Biogen
13.11. Bluebird bio, Inc.
13.12. Dynavax Technologies
13.13. Editas Medicine
13.14. Gilead Sciences, Inc.
13.15. Human Stem Cells Institute
13.16. Jazz Pharmaceuticals, Inc.
13.17. Merck & Co., Inc
13.18. MolMed S.p.A.
13.19. Novartis AG
13.20. Orchard Therapeutics plc.
13.21. Sarepta Therapeutics, Inc.
13.22. Sibiono GeneTech Co. Ltd.
13.23. Spark Therapeutics, Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL GENE THERAPY MARKET: DYNAMICS
FIGURE 2. GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2027
FIGURE 5. GLOBAL GENE THERAPY MARKET SIZE, BY ANTIGEN GENE THERAPY, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL GENE THERAPY MARKET SIZE, BY ANTIGEN GENE THERAPY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL GENE THERAPY MARKET SIZE, BY CANCER GENE THERAPY, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL GENE THERAPY MARKET SIZE, BY CANCER GENE THERAPY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL GENE THERAPY MARKET SIZE, BY CYTOKINE GENE THERAPY, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL GENE THERAPY MARKET SIZE, BY CYTOKINE GENE THERAPY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL GENE THERAPY MARKET SIZE, BY SUICIDE GENE THERAPY, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL GENE THERAPY MARKET SIZE, BY SUICIDE GENE THERAPY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL GENE THERAPY MARKET SIZE, BY TUMOR SUPPRESSOR GENE THERAPY, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL GENE THERAPY MARKET SIZE, BY TUMOR SUPPRESSOR GENE THERAPY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2021 VS 2027 (%)
FIGURE 16. GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2027
FIGURE 18. GLOBAL GENE THERAPY MARKET SIZE, BY NON-VIRAL VECTORS, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL GENE THERAPY MARKET SIZE, BY NON-VIRAL VECTORS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL GENE THERAPY MARKET SIZE, BY VIRAL VECTORS, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL GENE THERAPY MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 23. GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2027
FIGURE 25. GLOBAL GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL GENE THERAPY MARKET SIZE, BY GENETIC DISEASES, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL GENE THERAPY MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL GENE THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL GENE THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL GENE THERAPY MARKET SIZE, BY ONCOLOGICAL DISORDERS, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL GENE THERAPY MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. AMERICAS GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. ARGENTINA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. BRAZIL GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. CANADA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. MEXICO GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. UNITED STATES GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. ASIA-PACIFIC GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. AUSTRALIA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. CHINA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. INDIA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. INDONESIA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. JAPAN GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. MALAYSIA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. PHILIPPINES GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. SINGAPORE GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. SOUTH KOREA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. TAIWAN GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. THAILAND GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. FRANCE GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. GERMANY GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. ITALY GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. NETHERLANDS GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. QATAR GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. RUSSIA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. SAUDI ARABIA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. SOUTH AFRICA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. SPAIN GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. UNITED KINGDOM GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. GLOBAL GENE THERAPY MARKET: FPNV POSITIONING MATRIX
FIGURE 66. GLOBAL GENE THERAPY MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 67. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL GENE THERAPY MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL GENE THERAPY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL GENE THERAPY MARKET SIZE, BY ANTIGEN GENE THERAPY, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS GENE THERAPY MARKET SIZE, BY ANTIGEN GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES GENE THERAPY MARKET SIZE, BY ANTIGEN GENE THERAPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY ANTIGEN GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY ANTIGEN GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL GENE THERAPY MARKET SIZE, BY CANCER GENE THERAPY, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS GENE THERAPY MARKET SIZE, BY CANCER GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES GENE THERAPY MARKET SIZE, BY CANCER GENE THERAPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY CANCER GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY CANCER GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL GENE THERAPY MARKET SIZE, BY CYTOKINE GENE THERAPY, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS GENE THERAPY MARKET SIZE, BY CYTOKINE GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES GENE THERAPY MARKET SIZE, BY CYTOKINE GENE THERAPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY CYTOKINE GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY CYTOKINE GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL GENE THERAPY MARKET SIZE, BY SUICIDE GENE THERAPY, BY REGION, 2019-2027 (USD MILLION)
TABLE 20. AMERICAS GENE THERAPY MARKET SIZE, BY SUICIDE GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES GENE THERAPY MARKET SIZE, BY SUICIDE GENE THERAPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY SUICIDE GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY SUICIDE GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. GLOBAL GENE THERAPY MARKET SIZE, BY TUMOR SUPPRESSOR GENE THERAPY, BY REGION, 2019-2027 (USD MILLION)
TABLE 25. AMERICAS GENE THERAPY MARKET SIZE, BY TUMOR SUPPRESSOR GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES GENE THERAPY MARKET SIZE, BY TUMOR SUPPRESSOR GENE THERAPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY TUMOR SUPPRESSOR GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY TUMOR SUPPRESSOR GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL GENE THERAPY MARKET SIZE, BY NON-VIRAL VECTORS, BY REGION, 2019-2027 (USD MILLION)
TABLE 31. AMERICAS GENE THERAPY MARKET SIZE, BY NON-VIRAL VECTORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES GENE THERAPY MARKET SIZE, BY NON-VIRAL VECTORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY NON-VIRAL VECTORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY NON-VIRAL VECTORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. GLOBAL GENE THERAPY MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2019-2027 (USD MILLION)
TABLE 36. AMERICAS GENE THERAPY MARKET SIZE, BY VIRAL VECTORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES GENE THERAPY MARKET SIZE, BY VIRAL VECTORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 38. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY VIRAL VECTORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY VIRAL VECTORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL GENE THERAPY MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 47. AMERICAS GENE THERAPY MARKET SIZE, BY GENETIC DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. UNITED STATES GENE THERAPY MARKET SIZE, BY GENETIC DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 49. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY GENETIC DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY GENETIC DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. GLOBAL GENE THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 52. AMERICAS GENE THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. UNITED STATES GENE THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 54. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. GLOBAL GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 57. AMERICAS GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. UNITED STATES GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 59. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. GLOBAL GENE THERAPY MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 62. AMERICAS GENE THERAPY MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. UNITED STATES GENE THERAPY MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 64. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. AMERICAS GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 67. ARGENTINA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 68. BRAZIL GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 69. CANADA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 70. MEXICO GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. UNITED STATES GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 72. ASIA-PACIFIC GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 73. AUSTRALIA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 74. CHINA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. INDIA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. INDONESIA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 77. JAPAN GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 78. MALAYSIA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. PHILIPPINES GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. SINGAPORE GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. SOUTH KOREA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 82. TAIWAN GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. THAILAND GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. FRANCE GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. GERMANY GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. ITALY GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. NETHERLANDS GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. QATAR GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. RUSSIA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. SAUDI ARABIA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. SOUTH AFRICA GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. SPAIN GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. UNITED KINGDOM GENE THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. GLOBAL GENE THERAPY MARKET: SCORES
TABLE 97. GLOBAL GENE THERAPY MARKET: BUSINESS STRATEGY
TABLE 98. GLOBAL GENE THERAPY MARKET: PRODUCT SATISFACTION
TABLE 99. GLOBAL GENE THERAPY MARKET: RANKING
TABLE 100. GLOBAL GENE THERAPY MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 101. GLOBAL GENE THERAPY MARKET: MERGER & ACQUISITION
TABLE 102. GLOBAL GENE THERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 103. GLOBAL GENE THERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 104. GLOBAL GENE THERAPY MARKET: INVESTMENT & FUNDING
TABLE 105. GLOBAL GENE THERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 106. GLOBAL GENE THERAPY MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abeona Therapeutics, Inc.,
  • Achieve Life Sciences, Inc.
  • Adaptimmune
  • AGTC
  • Akcea Therapeutics
  • Alnylam Pharmaceuticals, Inc.
  • Amgen, Inc.
  • AnGes, Inc.
  • Audentes Therapeutics
  • Biogen
  • Bluebird bio, Inc.
  • Dynavax Technologies
  • Editas Medicine
  • Gilead Sciences, Inc.
  • Human Stem Cells Institute
  • Jazz Pharmaceuticals, Inc.
  • Merck & Co., Inc
  • MolMed S.p.A.
  • Novartis AG
  • Orchard Therapeutics plc.
  • Sarepta Therapeutics, Inc.
  • Sibiono GeneTech Co. Ltd.
  • Spark Therapeutics, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...